Different doses of Metoprolol.

Phase 3Small molecule

XXiangya Hospital of Central South University

Different doses of Metoprolol. is one of 13 small molecule programs targeting COPD. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

COPDNot yet recruiting

COPDPhase 3

Not yet recruiting

Competition

Competitive Landscape

17 competitors in COPD

#DrugCompanyPhaseTrials

Spiriva

Boehringer Ingelheim

Approved

13 2

Daliresp

AstraZeneca

Approved

2 3

Striverdi Respimat

Boehringer Ingelheim

Approved

5 4

Zithromax

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

2 5

Marinol

Jazz Pharmaceuticals

Phase 3

1 6

Different doses of Metoprolol.

XXiangya Hospital of Central South University

Phase 3

1 7

Medrol

Pfizer

Preclinical

1 8

Dexpramipexole Dihydrochloride

AAreteia Therapeutics

Phase 2

1 9

DUPIXENT

Regeneron

Preclinical

—10

Xopenex Hfa

HHikma Pharmaceuticals LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Post-ApprovalNot yet recruiting

COPD

NCT06825728

Clinical

Trials by Indication[1]

COPD1 trial

Metoprolol in Patients With HFrEF and COPD

Not yet recruiting·XXiangya Hospital of Central South University·Phase 4·NCT06825728·311 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Different doses of Metoprolol.. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Different doses of Metoprolol. compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Different doses of Metoprolol.. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Xiangya Hospital of Central South University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: XXiangya Hospital of Central South University

Different doses of Metoprolol.

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

COPD1 trial

References

Drug Info

Quick Facts

Related News